Poland· PL-100440167
Zimbus Breezhaler
A indacaterol, glycopyrronium bromid und mometason product containing indacaterolum + glycopyrronium + mometasoni furoas, registered in Poland by Novartis Europharm Limited. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Indacaterol, glycopyrronium bromid und mometason is registered in 11 of 19 countries.
Countries holding a registration under ATC R03AL12 (indacaterol, glycopyrronium bromid und mometason), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Indacaterol, glycopyrronium bromid und mometason · ATC R03AL12
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Indacaterolum + Glycopyrronium + Mometasoni furoas
- Manufacturer
- Novartis Europharm Limited
- Country
- Poland (PL)
- ATC code
- R03AL12
- ATC class
- Indacaterol, Glycopyrronium bromid und Mometason
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Indacaterol, glycopyrronium bromid und mometason in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandEnerzair Breezhaler Inha
- SpainENERZAIR BREEZHALER 114 MICROGRAMOS/46 MICROGRAMOS/136 MICROGRAMOS POLVO PARA INHALACION (CAPSULA DURA)Novartis Europharm Limited
- IcelandEnerzair BreezhalerNovartis Europharm Limited*
- NetherlandsEnerzair Breezhaler 114 micrograms/46 micrograms/136 micrograms, inhalatiepoeder in harde capsuleNovartis Europharm Limited
- CanadaENERZAIR BREEZHALERNOVARTIS PHARMACEUTICALS CANADA INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/01bc27b2-b162-4a9e-8c20-71bef2348666 GET /v1/drugs/01bc27b2-b162-4a9e-8c20-71bef2348666?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do inhalacji w kapsułkach twardych",
"source": "urpl",
"strength": "(114 mcg + 46 mcg + 136 mcg)/dawkę",
"packaging": "Rp ¦ EU/1/20/1440/001 ¦ 137365\n10 kaps. ¦ 1 inhalator \nRp ¦ EU/1/20/1440/002 ¦ 137366\n30 kaps. ¦ 1 inhalator \nRp ¦ EU/1/20/1440/003 ¦ 137367\n30 kaps. ¦ 1 inhalator + 1 czujnik\nRp ¦ EU/1/20/1440/004 ¦ 137368\n90 kaps. ¦ 1 inhalator \nRp ¦ EU/1/20/1440/005 ¦ 137369\n150 kaps. ¦ 15 inhalatorów",
"substance": "Indacaterolum 114 mcg/dawkę + Glycopyrronium 46 mcg/dawkę + Mometasoni furoas 136 mcg/dawkę",
"common_name": "Indacaterolum + Glycopyrronium + Mometasoni furoas",
"pl_product_id": "100440167",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about indacaterol, glycopyrronium bromid und mometason.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.